A point mutation in CD28 distinguishes proliferative signals from survival signals

被引:168
作者
Okkenhaug, K
Wu, L
Garza, KM
La Rose, J
Khoo, W
Odermatt, B
Mak, TW
Ohashi, PS
Rottapel, R [1 ]
机构
[1] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A2, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A2, Canada
[3] Univ Toronto, Dept Med, Toronto, ON M5S 1A2, Canada
[4] Ontario Canc Inst, Toronto, ON M5G 2M9, Canada
[5] Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada
[6] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland
[7] Amgen Inst, Toronto, ON, Canada
[8] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
基金
英国医学研究理事会;
关键词
D O I
10.1038/86327
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Upon interaction with its ligand, B7, CD28 becomes phosphorylated on tyrosines, One tyrosine in particular (Y-170 in mouse CD28, Y-173 in human CD28) has received much attention. This is because it permits CD28 to recruit SH2-containing signaling molecules, including phosphoinositide 3 kinase, Grb2 and Gads. Using mice we employed a transgenic approach to express a tyrosine-->phenylalanine mutant form of CD28 that uncouples these SH2-mediated interactions from CD28. The CD28 mutant is unable to up-regulate expression of the prosurvival protein Bcl-x(L), rendering the T cells move susceptible to radiation-induced death. Nonetheless, this mutated form of CD28 still prevents the induction of anergy and promotes T cell proliferation, interleukin 2 secretion and B cell help. Thus, we describe a single point mutation within the CD28 cytoplasmic domain that uncouples signals required for proliferation and survival.
引用
收藏
页码:325 / 332
页数:8
相关论文
共 48 条
[1]   CD28 OF T-LYMPHOCYTES ASSOCIATES WITH PHOSPHATIDYLINOSITOL 3-KINASE [J].
AUGUST, A ;
DUPONT, B .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (05) :769-774
[2]  
Barz C, 1998, J IMMUNOL, V161, P5366
[3]   CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L) [J].
BOISE, LH ;
MINN, AJ ;
NOEL, PJ ;
JUNE, CH ;
ACCAVITTI, MA ;
LINDSTEN, T ;
THOMPSON, CB .
IMMUNITY, 1995, 3 (01) :87-98
[4]   SELECTIVE CD28PYMNM MUTATIONS IMPLICATE PHOSPHATIDYLINOSITOL 3-KINASE IN CD86-CD28-MEDIATED COSTIMULATION [J].
CAI, YC ;
CEFAI, D ;
SCHNEIDER, H ;
RAAB, M ;
NABAVI, N ;
RUDD, CE .
IMMUNITY, 1995, 3 (04) :417-426
[5]  
Céfai D, 1998, J IMMUNOL, V160, P2223
[6]   CD28 can promote T cell survival through a phosphatidylinositol 3-kinase-independent mechanism [J].
Collette, Y ;
Razanajaona, D ;
Ghiotto, H ;
Olive, D .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) :3283-3289
[7]  
CROOKS MEC, 1995, MOL CELL BIOL, V15, P6820
[8]   Expression of Bcl-XL restores cell survival, but not proliferation and effector differentiation, in CD28-deficient T lymphocytes [J].
Dahl, AM ;
Klein, C ;
Andres, PG ;
London, CA ;
Lodge, MP ;
Mulligan, RC ;
Abbas, AK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (12) :2031-2037
[9]  
Downward J, 1996, CANCER SURV, V27, P87
[10]   GRID: A novel Grb-2-related adapter protein that interacts with the activated T cell costimulatory receptor CD28 [J].
Ellis, JH ;
Ashman, C ;
Burden, MN ;
Kilpatrick, KE ;
Morse, MA ;
Hamblin, PA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (11) :5805-5814